IOVANCE BIOTHERAPEUTICS, INC. Current Assets
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Current Assets of $464.26 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $464.26M.
- 2026-03-31: Assets, Current $466.50M.
- 2025-12-31: Assets, Current $442.69M.
- 2025-09-30: Assets, Current $429.09M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $464.26M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $466.50M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $442.69M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $429.09M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $422.50M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $512.65M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $457.02M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $498.58M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $482.26M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $385.53M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $307.85M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $382.59M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $274.88M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $637.78M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $479.12M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $369.88M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $431.59M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $489.97M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $507.96M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $583.03M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $666.64M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $605.22M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $636.10M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $723.59M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $782.65M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $256.38M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $316.49M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $367.31M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $410.94M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $444.75M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $475.37M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $265.86M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $279.78M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $302.73M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $149.29M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $171.38M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $135.43M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $152.59M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $169.51M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $180.56M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $192.35M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $99.36M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $103.98M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $110.39M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $112.71M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $111.41M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $44.98M 10-K · filed 2016-03-11 | $44.98M 10-K · filed 2015-03-16 |
| 2014-09-30 | $17.23M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $18.52M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $18.07M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $19.85M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $138.68K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $578.72K 10-Q · filed 2013-10-23 | |
| 2013-03-31 | $8.15K 10-Q · filed 2013-10-23 | |
| 2012-12-31 | $7.28K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $5.00K 10-Q · filed 2013-01-25 | |
| 2012-06-30 | $24.37K 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $34.05K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $524.08K 10-K · filed 2013-09-23 | |
| 2011-09-30 | $3.30M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $326.06K 10-Q/A · filed 2011-09-01 | |
| 2010-12-31 | $1.30M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |